Catalyst Event
Eli Lilly and Co (LLY) · Other
From KEDI U.S. Medical AI Index (KUSMAI)
4/30/2026, 12:00:00 AM
The U.S. FDA proposed removing tirzepatide, the active ingredient in Mounjaro and Zepbound, from the bulk drug substances list on 2026-04-30, restricting compounded versions. This regulatory protection of market share is estimated to result in a >10% price impact.
Korean Translation
2026년 4월 30일, 미국 FDA가 티르제파티드를 대량 원료의약품 목록에서 제외 제안하여 복제약 제조를 제한함. 시장 점유율 보호 효과로 인해 10% 이상의 주가 영향이 예상됨.
Related Recent Events
Alphabet Inc (GOOGL) · Other
Ex-dividend date (2026-06-08) for a quarterly cash dividend of $0.22 per share, representing a 5% increase from the prior dividend. The dividend was declared on April 27, 2026 and is payable on June 15, 2026. A 1-2% price impact is estimated as dividend increases are generally viewed positively by the market, scheduled.
6/8/2026, 12:00:00 AM
Tempus AI Inc (TEM) · Other
Tempus to host its inaugural Investor Day on May 29, 2026, starting at 8:00 a.m. CT, scheduled.
5/29/2026, 12:00:00 AM
NVIDIA Corporation (NVDA) · Earnings Release
NVIDIA is scheduled to announce its financial results for the first quarter of fiscal year 2027, which ended on April 26, 2026. A conference call will be held on the same day. Market impact is estimated as Neutral until the actual financial data is released, scheduled.
5/20/2026, 12:00:00 AM
BioNTech SE (BNTX) · Other
The Annual General Meeting 2026 is scheduled to be held as a virtual event on May 15, 2026, scheduled. Medium impact estimated as AGMs provide critical updates on corporate governance and long-term strategy.
5/15/2026, 12:00:00 AM
Hims & Hers Health Inc (HIMS) · Earnings Release
Q1 2026 earnings results are scheduled to be released after market close on May 11, 2026. High impact expected due to historical earnings volatility; scheduled.
5/11/2026, 12:00:00 AM
Caris Life Sciences Inc (CAI) · Earnings Release
Caris Life Sciences to report first quarter 2026 financial results on May 7, 2026, scheduled.
5/7/2026, 12:00:00 AM